(PSNY) Polestar Automotive Holding - Overview
Stock: Electric Vehicles, Accessories, Software, Carbon Credits, Leasing
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 244% |
| Relative Tail Risk | -6.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.18 |
| Alpha | -59.85 |
| Character TTM | |
|---|---|
| Beta | 1.359 |
| Beta Downside | 1.371 |
| Drawdowns 3y | |
|---|---|
| Max DD | 92.94% |
| CAGR/Max DD | -0.56 |
Description: PSNY Polestar Automotive Holding January 14, 2026
Polestar Automotive Holding UK PLC (NASDAQ: PSNY) designs, develops, markets and sells premium battery-electric vehicles (BEVs) and related technology. Its current lineup includes the Polestar 2 fast-back sedan, the Polestar 3 sport-utility vehicle, the Polestar 4 compact SUV, the Polestar 5 grand-touring sedan and the upcoming Polestar 6 roadster, complemented by accessories, software kits, carbon-credit sales and leasing services. The company was founded in 2017 and is headquartered in Gothenburg, Sweden.
Key quantitative context (as of FY 2023): Polestar reported delivery of approximately 86,000 units worldwide, a 35 % YoY increase driven by strong demand in Europe and North America; its gross margin on vehicle sales hovered around 18 %, reflecting higher mix of higher-priced models and cost efficiencies from its partnership with Geely. Macro-level, global EV registrations grew ~20 % YoY in 2023, while battery-pack prices continued to fall at roughly 6 % per annum, both of which underpin Polestar’s growth outlook. A sector-wide driver is the tightening of EU emissions regulations, which incentivizes premium BEV adoption and supports higher pricing power for brands with strong software and performance differentiation.
For a deeper, data-rich assessment of Polestar’s valuation and risk profile, consider exploring the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -1.78b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.32 > 0.02 and ΔFCF/TA 26.34 > 1.0 |
| NWC/Revenue: -116.8% < 20% (prev -35.57%; Δ -81.18% < -1%) |
| CFO/TA -0.23 > 3% & CFO -845.5m > Net Income -1.78b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (70.5m) vs 12m ago 0.22% < -2% |
| Gross Margin: -15.72% > 18% (prev -0.21%; Δ -1550 % > 0.5%) |
| Asset Turnover: 67.51% > 50% (prev 55.26%; Δ 12.25% > 0%) |
| Interest Coverage Ratio: -0.14 > 6 (EBITDA TTM -5.84m / Interest Expense TTM 288.5m) |
Altman Z'' -13.78
| A: -0.82 (Total Current Assets 2.21b - Total Current Liabilities 5.20b) / Total Assets 3.64b |
| B: -2.22 (Retained Earnings -8.10b / Total Assets 3.64b) |
| C: -0.01 (EBIT TTM -40.5m / Avg Total Assets 3.79b) |
| D: -1.03 (Book Value of Equity -8.11b / Total Liabilities 7.91b) |
| Altman-Z'' Score: -13.78 = D |
Beneish M -3.28
| DSRI: 1.02 (Receivables 419.4m/349.1m, Revenue 2.56b/2.18b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.77 (AQ_t 0.30 / AQ_t-1 0.39) |
| SGI: 1.18 (Revenue 2.56b / 2.18b) |
| TATA: -0.26 (NI -1.78b - CFO -845.5m) / TA 3.64b) |
| Beneish M-Score: -3.28 (Cap -4..+1) = AA |
What is the price of PSNY shares?
Over the past week, the price has changed by +28.35%, over one month by -6.54%, over three months by -15.05% and over the past year by -39.50%.
Is PSNY a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the PSNY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1 | -94.9% |
| Analysts Target Price | 1 | -94.9% |
| ValueRay Target Price | 11.1 | -43% |
PSNY Fundamental Data Overview February 03, 2026
P/B = 1.7263
Revenue TTM = 2.56b USD
EBIT TTM = -40.5m USD
EBITDA TTM = -5.84m USD
Long Term Debt = 2.38b USD (from longTermDebt, last quarter)
Short Term Debt = 3.21b USD (from shortTermDebt, last quarter)
Debt = 5.65b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.93b USD (from netDebt column, last quarter)
Enterprise Value = 6.25b USD (1.33b + Debt 5.65b - CCE 718.6m)
Interest Coverage Ratio = -0.14 (Ebit TTM -40.5m / Interest Expense TTM 288.5m)
EV/FCF = -5.43x (Enterprise Value 6.25b / FCF TTM -1.15b)
FCF Yield = -18.40% (FCF TTM -1.15b / Enterprise Value 6.25b)
FCF Margin = -44.97% (FCF TTM -1.15b / Revenue TTM 2.56b)
Net Margin = -69.67% (Net Income TTM -1.78b / Revenue TTM 2.56b)
Gross Margin = -15.72% ((Revenue TTM 2.56b - Cost of Revenue TTM 2.96b) / Revenue TTM)
Gross Margin QoQ = 1.43% (prev 1.43%)
Tobins Q-Ratio = 1.72 (Enterprise Value 6.25b / Total Assets 3.64b)
Interest Expense / Debt = 1.62% (Interest Expense 91.2m / Debt 5.65b)
Taxrate = 21.0% (US default 21%)
NOPAT = -32.0m (EBIT -40.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.43 (Total Current Assets 2.21b / Total Current Liabilities 5.20b)
Debt / Equity = -1.32 (negative equity) (Debt 5.65b / totalStockholderEquity, last quarter -4.27b)
Debt / EBITDA = -844.2 (out of range, set to none) (Net Debt 4.93b / EBITDA -5.84m)
Debt / FCF = -4.28 (negative FCF - burning cash) (Net Debt 4.93b / FCF TTM -1.15b)
Total Stockholder Equity = -3.42b (last 4 quarters mean from totalStockholderEquity)
RoA = -47.04% (Net Income -1.78b / Total Assets 3.64b)
RoE = 52.13% (negative equity) (Net Income TTM -1.78b / Total Stockholder Equity -3.42b)
RoCE = 3.90% (negative capital employed) (EBIT -40.5m / Capital Employed (Equity -3.42b + L.T.Debt 2.38b))
RoIC = -2.43% (negative operating profit) (NOPAT -32.0m / Invested Capital 1.31b)
WACC = 3.11% (E(1.33b)/V(6.97b) * Re(10.92%) + D(5.65b)/V(6.97b) * Rd(1.62%) * (1-Tc(0.21)))
Discount Rate = 10.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -81.72%
Fair Price DCF = unknown (Cash Flow -1.15b)
EPS Correlation: -19.77 | EPS CAGR: 31.37% | SUE: 0.55 | # QB: 0
Revenue Correlation: 40.74 | Revenue CAGR: 41.15% | SUE: 3.53 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.17 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.42 | Chg30d=-0.115 | Revisions Net=-2 | Growth EPS=+23.2% | Growth Revenue=+44.5%